A phase I/II study of cisplatin and radiation in combination with sorafenib in cervical cancer
Phase of Trial: Phase I/II
Latest Information Update: 01 Jan 2016
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin
- Indications Cervical cancer
- Focus Therapeutic Use
- 29 Jul 2015 Last checked against ClinicalTrials.gov record.
- 13 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Oct 2011 Planned end date changed from 1 Jul 2010 to 1 Apr 2012 as reported by ClinicalTrials.gov.